Internetiühendust pole — kuvatakse lehe salvestatud versioon.

Viridian Therapeu…

USUSD
← Aktsiafiltri Juurde
US:VRDNLSE:0K1R

Viridian Therapeutics Inc (US:VRDN) — Biotechnology: Pharmaceutical Preparations. Börside arv, kus ettevõtte aktsiatega kaubeldakse: 2. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.

Ettevõtte Kohta

Veebileht
viridiantherapeutics.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Peakontor
WALTHAM, United States
Tegevjuht
Stephen F. Mahoney
Töötajad
252
Ringluses Olevad Aktsiad
113.29 mln seisuga 2026-08-03
Vabalt Kaubeldavad Aktsiad
100.65 mln
Turukapitalisatsioon
2.11 mld USD
Siseringi Isikud
0.17%
Institutsionaalsed Investorid
126.76%
Tegevusala (SIC)
Pharmaceutical Preparations
P/E
kahjum
FCF
−335 mln USD
Võlg
20.9 mln USD
Kasum ja FCF — 12 kuu jooksul kuni 30.06.2026 (ettevõtte viimane raport).
Kirjeldus

Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered, and Elegrobart, a low-volume, infrequently dosed subcutaneous IGF-1R. The company also develops an anti-thyroid-stimulating hormone receptor (TSHR) candidate for the treatment of Graves' disease and TED. Its portfolio of engineered inhibitors of the neonatal Fc receptor (FcFn) includes VRDN-006, a highly selective Fc fragment, and VRDN-008, a half-life extended bispecific FcRn inhibitor comprising an GC fragment and an albumin-binding domain designed to prolong IGG suppression. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was incorporated in 2010 and is headquartered in Waltham, Massachusetts.

reklaam

Börsid ja Tikkerid

BörsTikkerValuutaHindTüüp
US USA StocksVRDN põhinoteeringUSD18.66 +1.74%tavalised aktsiad
LSE London Stock Exchange0K1R IOBUSD18.18 +0.00%tavalised aktsiad

Hind 3 Kuu Jooksul

3M1Y3Y5Y
tõususepäev langusepäevViige kursor / puudutage päeva — avamis-, sulgemis-, kõrgeim ja madalaim hind

Suurimad Omanikud

OmanikOsalusAktsiadAruande Kuupäev
FMR, LLC14.66%16.6 mln2026-06-30
Blackrock Inc.7.55%8.55 mln2026-06-30
Bellevue Group AG5.94%6.73 mln2026-06-30
Paradigm Biocapital Advi…5.93%6.72 mln2026-06-30
Kynam Capital Management…5.7%6.45 mln2026-06-30
State Street Corporation5.41%6.12 mln2026-06-30
Price (T.Rowe) Associate…5.07%5.75 mln2026-06-30
Fairmount Funds Manageme…4.49%5.09 mln2026-06-30
Vanguard Capital Managem…4.04%4.58 mln2026-06-30
SPDR SERIES TRUST-State…3.65%4.13 mln2026-08-31
Deep Track Capital, Lp3.17%3.59 mln2026-06-30
VANGUARD INDEX FUNDS-Van…2.95%3.34 mln2026-06-30
iShares Trust-iShares Ru…2.04%2.31 mln2026-08-31
Fidelity Advisor Series…1.57%1.78 mln2026-08-31
Fidelity Select Portfoli…1.32%1.5 mln2026-08-31
T. Rowe Price Health Sci…1.28%1.45 mln2026-06-30
Fidelity Rutland Square…1.23%1.4 mln2026-08-31
T. Rowe Price New Horizo…1.19%1.35 mln2026-06-30
Fidelity Select Portfoli…1.15%1.31 mln2026-08-31
Fidelity Securities Fund…1.12%1.27 mln2026-07-31
TRIPURANENI RADHIKA (Off…≈0.04%40 0002026-08-14
MAHONEY STEPHEN F (Chief…≈0.03%33 3492026-03-03
BEETHAM THOMAS W (Chief…≈0.01%13 3612026-03-03
HARMON SETH (Chief Finan…≈0.01%7 7902026-03-03
TOUSIGNANT JENNIFER (Off…—02026-08-19